City

Clinical trials near Aurora, United States

Active studies with a listed research site in Aurora, United States.

52active studies

23recruiting now

17countries represented

77largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowNot applicable

HealthyTogether: RCT of a Dyadic Weight Management Intervention

Obesity, OverweightCondition

HealthyTogetherTreatment

United States2 locations

VA Office of Research and DevelopmentSponsor

Updated 2026-09-01 · NCT06619041See eligibility →

Recruiting nowPhase 3

Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome

PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, ObeseCondition

Semaglutide Injectable Product (Wegovy and/or Ozempic)Treatment

United States1 locations

University of Colorado, DenverSponsor

Updated 2026-08-31 · NCT05819853See eligibility →

Recruiting nowNot applicable

Effects of GLP-1 RAs on Human Lactation Outcomes

Lactation, Weight LossCondition

Injected GLP-1 Receptor Agonists and Dual AgonistsTreatment

United States1 locations

University of Colorado, DenverSponsor

Updated 2026-07-22 · NCT07720414See eligibility →

Recruiting nowPhase 2, Phase 3

Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

Menopause, Menopause Hot FlashesCondition

Metformin, semaglutideTreatment

United States3 locations

University of Colorado, DenverSponsor

Updated 2026-07-21 · NCT06975111See eligibility →

Recruiting nowPhase 2

Convergent Mechanisms Underlying Reprometabolic Syndrome in Women

Infertility, Female, ObesityCondition

Estradiol PatchesTreatment

United States2 locations

University of Colorado, DenverSponsor

Updated 2026-07-21 · NCT06686537See eligibility →

Recruiting nowPhase 2

Multi-Site Trial of Tirzepatide for Smoking Cessation

Smoking Cessation, Smoking BehaviorsCondition

Tirzepatide, PlaceboTreatment

United States4 locations

University of Southern CaliforniaSponsor

Updated 2026-07-17 · NCT07602699See eligibility →

Recruiting nowPhase 1

Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents

Obesity, Adolescent ObesityCondition

Injectable semaglutide or injectable tirzepatide, Standard postoperative careTreatment

United States1 locations

University of Colorado, DenverSponsor

Updated 2026-07-15 · NCT06575738See eligibility →

Recruiting nowPhase 2

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

Diabetic Kidney Disease, Type 1 DiabetesCondition

Semaglutide, PlaceboTreatment

Canada, United States4 locations

University of WashingtonSponsor

Updated 2026-06-02 · NCT05822609See eligibility →

Recruiting nowPhase 2

Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV

HIV-1-infection, FrailtyCondition

Tesamorelin, PlaceboTreatment

United States2 locations

Massachusetts General HospitalSponsor

Updated 2026-05-19 · NCT06554717See eligibility →

Recruiting nowNot applicable

Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling

Obesity, Insulin SensitivityCondition

Diet Weight LossTreatment

United States1 locations

University of Colorado, DenverSponsor

Updated 2026-05-15 · NCT06129110See eligibility →

Recruiting nowNot applicable

Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes

Type 2 Diabetes, Overweight and ObesityCondition

Cardiovascular exerciseTreatment

United States2 locations

University of Colorado, DenverSponsor

Updated 2026-03-23 · NCT04791371See eligibility →

Recruiting nowNot applicable

Snacking Effects on the Brain Response to Foods and Satiety During Dieting

Overweight/ObesityCondition

Snack Type 1: Walnuts, Snack Type 2: PretzelsTreatment

United States1 locations

University of Colorado, DenverSponsor

Updated 2026-03-23 · NCT07428187See eligibility →

Recruiting nowPhase 3

Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes

Diabetes Mellitus, Type 1Condition

Semaglutide Pen Injector, PlaceboTreatment

United States2 locations

University of Colorado, DenverSponsor

Updated 2026-03-04 · NCT05819138See eligibility →

Recruiting nowPhase 3

A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)

Hypothalamic Obesity, Multiple Pituitary Hormone Deficiency Genetic FormCondition

Setmelanotide, PlaceboTreatment

United Kingdom, United States11 locations

Rhythm Pharmaceuticals, Inc.Sponsor

Updated 2026-02-12 · NCT06760546See eligibility →

Recruiting nowNot applicable

Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity

Overweight and ObesityCondition

Active Implicit Priming, Control Implicit PrimingTreatment

United States1 locations

University of Colorado, DenverSponsor

Updated 2026-02-12 · NCT05107908See eligibility →

Recruiting nowPhase 2

Anti Inflammatory Lipid Mediators in Asthma Lipid Anti-Inflammtory Mediators in Asthma

Asthma, ObesityCondition

CXA-10, Matching PlaceboTreatment

United States1 locations

University of Colorado, DenverSponsor

Updated 2025-06-10 · NCT03762395See eligibility →

Recruiting nowPhase 2

Glucagon-Like Peptide-1 Receptor Agonist in ADPKD

Autosomal Dominant Polycystic Kidney, ObesityCondition

Tirzepatide, PlaceboTreatment

United States1 locations

University of Colorado, DenverSponsor

Updated 2025-05-06 · NCT06582875See eligibility →

Recruiting nowNot applicable

Thermogenenic Responses to Fasting and Overfeeding in Women

ObesityCondition

Eucalaloric feeding, Acute FastingTreatment

United States1 locations

University of Colorado, DenverSponsor

Updated 2025-04-30 · NCT06610162See eligibility →

Recruiting nowNot applicable

Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)

Type 2 Diabetes Mellitus, Diabetic Kidney DiseaseCondition

Aminohippurate Sodium Inj 20%, Iohexol Inj 300 MG/MLTreatment

United States2 locations

Petter BjornstadSponsor

Updated 2025-03-24 · NCT05008276See eligibility →

Recruiting nowPhase 1

Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome

Infertility, ObesityCondition

Follicle Stimulating HormoneTreatment

United States1 locations

University of Colorado, DenverSponsor

Updated 2024-11-27 · NCT06414096See eligibility →

Recruiting nowNot applicable

A Pilot Factorial Trial of an Integrated Lifestyle Intervention

Physical Inactivity, Overweight and ObesityCondition

Prevent T2, Move group-based classesTreatment

United States1 locations

University of Colorado, DenverSponsor

Updated 2024-05-14 · NCT06116435See eligibility →

Recruiting nowPhase 4

Bioenergetic Effects of Aging and Menopause (BEAM)

Menopause, Obesity, AbdominalCondition

GnRH antagonist, Estrogen ProductTreatment

United States1 locations

University of Colorado, DenverSponsor

Updated 2023-12-18 · NCT04043520See eligibility →

Recruiting nowNot applicable

Obesity, Metabolic Dysregulation and the Airway Epithelium in Asthmatics

Asthma, ObesityCondition

Bronchoscopy and Nasal Epithelium Brush SamplingTreatment

United States1 locations

University of Colorado, DenverSponsor

Updated 2023-02-02 · NCT03215836See eligibility →

Opening soonNot applicable

Digitally Enhanced Cognitive-Behavioral Therapy

Depression in Adolescence, Obesity & OverweightCondition

Cognitive-behavioral therapy (CBT), Digital appTreatment

United States1 locations

Colorado State UniversitySponsor

Updated 2026-09-03 · NCT07569991See eligibility →

Opening soonPhase 3

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Overweight, ObesityCondition

zenagamtide, PlaceboTreatment

United States37 locations

Novo Nordisk A/SSponsor

Updated 2026-08-25 · NCT07720271See eligibility →

Opening soonNot applicable

Exercise Effects on the Neurobiology Underlying Stress-related Eating Behaviors in Veterans

Overweight/Obesity, StressCondition

ExerciseTreatment

United States1 locations

VA Office of Research and DevelopmentSponsor

Updated 2026-08-24 · NCT06627569See eligibility →

Opening soonPhase 3

Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity

Obesity/TherapyCondition

Semaglutide 1.7mg subcutaneous, PlaceboTreatment

United States1 locations

University of Colorado, DenverSponsor

Updated 2026-07-02 · NCT07021937See eligibility →

Invitation onlyPhase 2

A Long-Term Study of Bivamelagon in Participants With Hypothalamic Obesity (HO)

Hypothalamic ObesityCondition

BivamelagonTreatment

United Kingdom, United States9 locations

Rhythm Pharmaceuticals, Inc.Sponsor

Updated 2026-02-10 · NCT07156578See eligibility →

Invitation onlyNot applicable

Linking Temporal Patterns of Modifiable Behaviors to Weight Loss Outcomes

Obesity, Weight Change, BodyCondition

Intervention not listedTreatment

United States1 locations

University of Colorado, DenverSponsor

Updated 2025-12-19 · NCT03840733See eligibility →

Invitation onlyNot applicable

Family Matters Intervention

Childhood Obesity, Cardiovascular Disease PreventionCondition

In-home Visits and Food Preparation Activities, Ecological Momentary InterventionTreatment

United States2 locations

University of Colorado, DenverSponsor

Updated 2025-09-22 · NCT02669797See eligibility →

Invitation onlyNot applicable

PATHWEIGH: Pragmatic Weight Management in Primary Care

ObesityCondition

Weight management care path, ControlTreatment

United States64 locations

University of Colorado, DenverSponsor

Updated 2025-05-30 · NCT04678752See eligibility →

Active, not recruitingNot applicable

Behavioral Weight Loss and Sleep Health Intervention

Overweight and Obese AdultsCondition

BWL+SleepTreatment

United States1 locations

University of Colorado, DenverSponsor

Updated 2026-09-03 · NCT07255287See eligibility →

Active, not recruitingNot applicable

BfedBwell INSPIRE Pilot

Cancer Survivorship, Overweight , ObesityCondition

BfedBwell - Core Curriculum, BfedBwell - 1:1 CounselingTreatment

United States1 locations

University of Colorado, DenverSponsor

Updated 2026-09-03 · NCT07446595See eligibility →

Active, not recruitingNot applicable

4:3 Intermittent Fasting Intervention in Adults With Breast Cancer and Overweight or Obesity

Breast CancerCondition

Weight LossTreatment

United States2 locations

University of Colorado, DenverSponsor

Updated 2026-09-01 · NCT06399276See eligibility →

Active, not recruitingPhase 3

A Trial of Setmelanotide in Acquired Hypothalamic Obesity

Hypothalamic ObesityCondition

Setmelanotide, PlaceboTreatment

Canada, Germany28 locations

Rhythm Pharmaceuticals, Inc.Sponsor

Updated 2026-08-10 · NCT05774756See eligibility →

Active, not recruitingPhase 3

Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide

Obesity, OverweightCondition

Cagrilintide, PlaceboTreatment

Argentina, Australia40 locations

Novo Nordisk A/SSponsor

Updated 2026-08-06 · NCT07220642See eligibility →

Active, not recruitingNot applicable

Timing Intervention of Morning Versus Evening Exercise

Overweight and ObesityCondition

Morning Exercise, Evening ExerciseTreatment

United States1 locations

University of Colorado, DenverSponsor

Updated 2026-07-30 · NCT05153252See eligibility →

Active, not recruitingPhase 3

A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity

ObesityCondition

Retatrutide, TirzepatideTreatment

Argentina, Germany65 locations

Eli Lilly and CompanySponsor

Updated 2026-07-20 · NCT06662383See eligibility →

Active, not recruitingPhase 2

A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

Overweight, ObesityCondition

Tirzepatide, PlaceboTreatment

Austria, Canada27 locations

Eli Lilly and CompanySponsor

Updated 2026-05-08 · NCT05536804See eligibility →

Active, not recruitingPhase 3

Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)

Diabetes Mellitus, Type 2Condition

Retatrutide, SemaglutideTreatment

Argentina, Canada77 locations

Eli Lilly and CompanySponsor

Updated 2026-04-13 · NCT06260722See eligibility →

Active, not recruitingPhase 4

Surgical or Medical Treatment

Diabetes Mellitus, Type 2, Pediatric ObesityCondition

Advanced Medical Therapy and Bariatric Surgery, Advanced Medical TherapyTreatment

United States3 locations

Children's Hospital Medical Center, CincinnatiSponsor

Updated 2026-03-24 · NCT04128995See eligibility →

Active, not recruitingNot applicable

Early vs. Late Time Restricted Eating vs. Daily Caloric Restriction

Overweight and ObesityCondition

Early TRE, Late TRETreatment

United States1 locations

University of Colorado, DenverSponsor

Updated 2026-03-24 · NCT05870982See eligibility →

Active, not recruitingPhase 2

A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity

Type 2 Diabetes, ObesityCondition

Tirzepatide, PlaceboTreatment

Argentina, Mexico40 locations

Eli Lilly and CompanySponsor

Updated 2026-03-23 · NCT06037252See eligibility →

Active, not recruitingPhase 3

A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity

ObesityCondition

Retatrutide, PlaceboTreatment

Canada, United Kingdom53 locations

Eli Lilly and CompanySponsor

Updated 2026-03-03 · NCT06859268See eligibility →

Active, not recruitingNot applicable

Reprometabolic Syndrome Mediates Subfertility in Obesity

Obesity, InfertilityCondition

Insulin, IntralipidTreatment

United States1 locations

University of Colorado, DenverSponsor

Updated 2026-03-02 · NCT02653092See eligibility →

Active, not recruitingNot applicable

Time and Nutrient-Dependent Effects of Aerobic Exercise on Metabolism in Adults (TANDEM Study)

Overweight and Obesity, HealthyCondition

Fasted-AM, Fed-AMTreatment

United States1 locations

University of Colorado, DenverSponsor

Updated 2025-12-19 · NCT06311487See eligibility →

Active, not recruitingNot applicable

Dietary Reversal of the Reprometabolic Syndrome

Obesity & Overweight, Infertility, FemaleCondition

Low-fat dietTreatment

United States1 locations

University of Colorado, DenverSponsor

Updated 2025-11-14 · NCT07227766See eligibility →

Active, not recruitingPhase 2

Metformin for Chemoprevention of Lung Cancer in Overweight or Obese Individuals at High Risk for Lung Cancer

Lung CarcinomaCondition

Biopsy, Biospecimen CollectionTreatment

Canada, United States4 locations

Northwestern UniversitySponsor

Updated 2025-10-07 · NCT04931017See eligibility →

Active, not recruitingNot applicable

Daily Caloric Restriction in ADPKD

Autosomal Dominant Polycystic Kidney, Overweight and ObesityCondition

Daily caloric restriction, Standard advice controlTreatment

United States1 locations

University of Colorado, DenverSponsor

Updated 2025-08-12 · NCT04907799See eligibility →

Active, not recruitingNot applicable

Childhood Obesity Treatment Designed for Low Income and Hispanic Families

Pediatric Obesity, Healthy EatingCondition

The Healthy Living Program/La Vida Saludable, Recommended Treatment of Obesity in Primary CareTreatment

United States2 locations

University of Colorado, DenverSponsor

Updated 2025-03-30 · NCT05041855See eligibility →

Active, not recruitingNot applicable

The AUDACITY Study (AllUrion Device in Adults With Clinical ObesITY)

ObesityCondition

AGBSTreatment

United States17 locations

Allurion TechnologiesSponsor

Updated 2024-10-26 · NCT05368259See eligibility →

Active, not recruitingPhase 1, Phase 2

Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study

Type 2 Diabetes Mellitus, ObesityCondition

Aminohippurate Sodium Inj 20%, Iohexol Inj 300 MG/MLTreatment

United States1 locations

University of Colorado, DenverSponsor

Updated 2023-08-15 · NCT03584217See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.

Clinical trials near Aurora, United States

Current studies

Related cities